Results 191 to 200 of about 88,362 (256)

Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT G protein‐coupled receptors (GPCRs) are integral to numerous biological processes and are associated with various diseases across all therapeutic areas. Consequently, GPCRs present substantial potential for antibody‐based therapies. This review offers an overview of the therapeutic GPCR‐antibody target landscape and examines the diversity ...
Catherine J. Hutchings, Serbülent Ünsal, Mathieu Rappas, Matthew Barnes, Maria Waldhoer, Ben Holland, Martin Culka   +6 more
wiley   +1 more source

Follicular Lymphoma [PDF]

, 2018
openaire   +2 more sources

Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study. [PDF]

Hemasphere
Dogliotti I, Tonino S, Conte L, Stepanishyna Y, Moita F, Brites Alves S, Jiménez-Ubieto A, Gonzalez de Villambrosia S, Cavallo F, Del Campo Garcia R, Zing N, Kersten MJ, Federico M, EHA LyG Cantera 2018.   +13 more
europepmc   +1 more source

Imaging findings and clinical outcome in three cats with possible inflammatory ureteritis

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract Three adult cats presented to our institution for evaluation of non‐specific clinical signs and azotaemia. All cats had sonographic evidence of renal pelvic and ureteral dilation, concerning for a ureteral obstruction without a definitive mechanical cause identified. Anti‐inflammatory doses of corticosteroids were administered over an extended
Elisa L. Heacock, Mei Lun Mui, Federica Serafini, Jennifer A. Reetz   +3 more
wiley   +1 more source

Mandibular Follicular Lymphoma: A Rare Extranodal Presentation With Initial Facial Bone Involvement. [PDF]

Cureus
Vital C, Leite PM, Martins M, Gomes P.
europepmc   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China. [PDF]

Front Pharmacol
Xu C, Yang S, Liu Y, Wu Y, Liu X, Zhong QZ, Yang Y, Wu T, Chen SY, Chen B, Song YW, Fang H, Jin J, Liu YP, Jing H, Tang Y, Li N, Lu NN, Zhang WW, Wang SL, Zhu J, Qi SN, Li YX.   +22 more
europepmc   +1 more source

Primary Cutaneous Peripheral T‐Cell Lymphoma With Follicular Helper T‐Cell Phenotype

Journal of Cutaneous Pathology, Volume 53, Issue 2, Page 147-152, February 2026.
ABSTRACT An otherwise healthy 82‐year‐old woman presented with recurrent, asymptomatic erythematous papulo‐nodular lesions on the face and extremities. A skin biopsy revealed a dense, non‐epidermotropic lymphohistiocytic infiltrate with granulomatous features and a mixed population of medium‐sized atypical lymphoid cells and plasma cells ...
Nidia Planella‐Fontanillas, Andrea Molina‐Alvarez, Lluís Colomo‐Saperas, Roger Rovira, Monica Gonzàlez‐Farré, Carlos Barranco‐Sanz, Xavier Calvo, Clara Nadal‐Pellisé, Fernando Gallardo, Ramon M. Pujol   +9 more
wiley   +1 more source

Acute obinutuzumab-induced thrombocytopenia in follicular lymphoma: case report and literature review. [PDF]

Front Oncol
Zhou J, Chen M, Zhang Y, Xu C, Li R.
europepmc   +1 more source

Primary Cutaneous B‐Cell Lymphomas: An Updated Portrait of Classification, Biology, and Clinical Management

European Journal of Haematology, Volume 116, Issue 2, Page 116-128, February 2026.
ABSTRACT Primary cutaneous B‐cell lymphomas (CBCL) represent a clinically and biologically heterogeneous group of extranodal non‐Hodgkin lymphomas confined to the skin at the time of diagnosis. They account for approximately 25% of all primary cutaneous lymphomas and are subclassified into distinct entities according to the World Health Organization ...
A. Bernardelli, E. Carazzai, B. Bugnotto, F. Bellinato, M. Krampera, C. Visco   +5 more
wiley   +1 more source